RN7SL608P

Across TCGA pan-cancer cohorts, RN7SL608P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RN7SL608P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL608P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL608P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

HNSC, KIRC, and STAD are the cancer types where RN7SL608P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL608P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.533	<.001	9	view →
KIRC	All	All	+0.340	<.001	7	view →
STAD	All	II,III,IV	+0.623	.004	6	view →
CHOL	Male	All	+1.739	<.001	5	view →
BRCA	All	III,IV	−0.440	.024	4	view →
LIHC	Female	II,III,IV	+0.448	.018	3	view →
KIRP	All	IV	+0.867	.008	2	view →
COAD	All	All	+0.398	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RN7SL608P–HNSC

Open the HNSC breakdown →